Literature DB >> 18769172

Whatever happened to Pittsburgh Compound-A?

William E Klunk1, Chester A Mathis.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18769172      PMCID: PMC2648817          DOI: 10.1097/WAD.0b013e318188c0c8

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


× No keyword cloud information.
  41 in total

Review 1.  Imaging beta-amyloid plaques and neurofibrillary tangles in the aging human brain.

Authors:  C A Mathis; Y Wang; W E Klunk
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

2.  Fluoro-substituted and 13C-labeled styrylbenzene derivatives for detecting brain amyloid plaques.

Authors:  Kumi Sato; Makoto Higuchi; Nobuhisa Iwata; Takaomi C Saido; Kazumi Sasamoto
Journal:  Eur J Med Chem       Date:  2004-07       Impact factor: 6.514

3.  Chrysamine G and its derivative reduce amyloid beta-induced neurotoxicity in mice.

Authors:  Kazuhiro Ishii; William E Klunk; Shigeki Arawaka; Manik L Debnath; Yoshiko Furiya; Naruhiko Sahara; Shin'ichi Shoji; Akira Tamaoka; Jay W Pettegrew; Hiroshi Mori
Journal:  Neurosci Lett       Date:  2002-11-15       Impact factor: 3.046

4.  A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain.

Authors:  Chester A Mathis; Brian J Bacskai; Stephen T Kajdasz; Megan E McLellan; Matthew P Frosch; Bradley T Hyman; Daniel P Holt; Yanming Wang; Guo-Feng Huang; Manik L Debnath; William E Klunk
Journal:  Bioorg Med Chem Lett       Date:  2002-02-11       Impact factor: 2.823

5.  Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative.

Authors:  William E Klunk; Brian J Bacskai; Chester A Mathis; Stephen T Kajdasz; Megan E McLellan; Matthew P Frosch; Manik L Debnath; Daniel P Holt; Yanming Wang; Bradley T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  2002-09       Impact factor: 3.685

6.  Neuroscience. Long-awaited technique spots Alzheimer's toxin.

Authors:  Laura Helmuth
Journal:  Science       Date:  2002-08-02       Impact factor: 47.728

7.  Targeting prion amyloid deposits in vivo.

Authors:  Marcin Sadowski; Joanna Pankiewicz; Henrieta Scholtzova; Julia Tsai; Yongsheng Li; Richard I Carp; Harry C Meeker; Pierluigi Gambetti; Manik Debnath; Chester A Mathis; Li Shao; Wen-Biao Gan; William E Klunk; Thomas Wisniewski
Journal:  J Neuropathol Exp Neurol       Date:  2004-07       Impact factor: 3.685

Review 8.  Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development.

Authors:  Mats Bergström; Anders Grahnén; Bengt Långström
Journal:  Eur J Clin Pharmacol       Date:  2003-08-22       Impact factor: 2.953

9.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.

Authors:  William E Klunk; Henry Engler; Agneta Nordberg; Yanming Wang; Gunnar Blomqvist; Daniel P Holt; Mats Bergström; Irina Savitcheva; Guo-feng Huang; Sergio Estrada; Birgitta Ausén; Manik L Debnath; Julien Barletta; Julie C Price; Johan Sandell; Brian J Lopresti; Anders Wall; Pernilla Koivisto; Gunnar Antoni; Chester A Mathis; Bengt Långström
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

10.  Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents.

Authors:  Chester A Mathis; Yanming Wang; Daniel P Holt; Guo-Feng Huang; Manik L Debnath; William E Klunk
Journal:  J Med Chem       Date:  2003-06-19       Impact factor: 7.446

View more
  5 in total

Review 1.  Development of positron emission tomography β-amyloid plaque imaging agents.

Authors:  Chester A Mathis; N Scott Mason; Brian J Lopresti; William E Klunk
Journal:  Semin Nucl Med       Date:  2012-11       Impact factor: 4.446

Review 2.  Small-molecule PET Tracers for Imaging Proteinopathies.

Authors:  Chester A Mathis; Brian J Lopresti; Milos D Ikonomovic; William E Klunk
Journal:  Semin Nucl Med       Date:  2017-07-13       Impact factor: 4.446

3.  A History of Senile Plaques: From Alzheimer to Amyloid Imaging.

Authors:  Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2022-05-20       Impact factor: 3.148

Review 4.  Amyloid Proteins and Their Role in Multiple Sclerosis. Considerations in the Use of Amyloid-PET Imaging.

Authors:  Jordi A Matías-Guiu; Celia Oreja-Guevara; María Nieves Cabrera-Martín; Teresa Moreno-Ramos; José Luis Carreras; Jorge Matías-Guiu
Journal:  Front Neurol       Date:  2016-03-31       Impact factor: 4.003

Review 5.  PET Radiopharmaceuticals for Alzheimer's Disease and Parkinson's Disease Diagnosis, the Current and Future Landscape.

Authors:  Bright Chukwunwike Uzuegbunam; Damiano Librizzi; Behrooz Hooshyar Yousefi
Journal:  Molecules       Date:  2020-02-21       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.